A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer.
about
Effect of FOLFIRINOX as second-line chemotherapy for metastatic pancreatic cancer after gemcitabine-based chemotherapy failure.Therapeutic efficacy and safety of S-1-based combination therapy compare with S-1 monotherapy following gemcitabine failure in pancreatic cancer: a meta-analysisS-1 monotherapy versus S-1 combination therapy in gemcitabine-refractory advanced pancreatic cancer: A meta-analysis (PRISMA) of randomized control trials.Intravenous and intraperitoneal paclitaxel with S-1 for treatment of refractory pancreatic cancer with malignant ascites.Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer: Regimen of 1 week on, 1 week off.Phase I clinical and pharmacokinetic study of S-1 plus oral leucovorin in patients with metastatic colorectal cancer.Chemotherapy in Pancreatic Cancer: A Systematic ReviewCurrent status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining?
P2860
Q33672571-6498220E-4E45-48CB-8578-C55FAEBCD7A8Q37408595-4C372948-B5E0-4598-874A-2A0D43420837Q38660283-27A9BCA1-32D8-4657-9276-FCF295E8A1DDQ40638288-B70232CA-6C36-4C94-BBA3-135DBF124295Q42288648-9B572E0A-85B3-43B8-A3C2-3BB26319DC99Q53641063-F09E7CC9-9B0F-4C6E-BE7F-220856358F55Q57824846-A6280687-5983-4D3D-813C-9A79896ED41CQ58799265-D93CE01D-2FC0-4B8D-A9C7-170D77F4DB9F
P2860
A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A randomized phase II study of ...... ry advanced pancreatic cancer.
@ast
A randomized phase II study of ...... ry advanced pancreatic cancer.
@en
type
label
A randomized phase II study of ...... ry advanced pancreatic cancer.
@ast
A randomized phase II study of ...... ry advanced pancreatic cancer.
@en
prefLabel
A randomized phase II study of ...... ry advanced pancreatic cancer.
@ast
A randomized phase II study of ...... ry advanced pancreatic cancer.
@en
P2093
P2860
P356
P1433
P1476
A randomized phase II study of ...... ry advanced pancreatic cancer.
@en
P2093
A Fukutomi
K Fukuzawa
K Sugimori
M Furukawa
P2860
P304
P356
10.1093/ANNONC/MDV603
P577
2015-12-17T00:00:00Z